Who owns Neurocrine Biosciences Inc Note 2.250 5/1?
- CUSIP Number: 64125cad1
Tip: Access positions for across all investors
Analyze quarterly positions in Neurocrine Biosciences Inc Note 2.250 5/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurocrine Biosciences Inc Note 2.250 5/1 stock
Who bought or sold Neurocrine Biosciences Inc Note 2.250 5/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 28M | $51M | -48% | Mar 2024 |
|
| Tenor Capital Management | 27M | $49B | 0% | Mar 2024 |
|
| D. E. Shaw & Co | 14M | $26M | 0% | Mar 2024 |
|
| Piper Jaffray & Co. | 14M | $25M | 100% | Mar 2024 |
|
| FMR | 10M | $18M | 100% | Mar 2024 |
|
| Lord, Abbett & Co | 6.7M | $12M | -46% | Mar 2024 |
|
| T. Rowe Price Associates | 2.6M | $4.7M | 100% | Mar 2024 |
|
| SSI Investment Management | 2.3M | $3.9M | -1% | Dec 2023 |
|
| Bnp Paribas Investment Partners | 1.6M | $2.9M | 0% | Mar 2024 |
|
| Agf Management | 1.2M | $2.2M | 0% | Mar 2024 |
|
| Rock Springs Capital Management | 1.0M | $1.8M | 0% | Mar 2024 |
|
| Citigroup | 998k | $1.8M | 4% | Mar 2024 |
|
| Barclays | 680k | $1.2M | 21% | Mar 2024 |
|
| Jane Street | 195k | $352k | -8% | Mar 2024 |
|
| American Century Companies | 157k | $285k | 69% | Mar 2024 |
|
| Fox Hill Wealth Management | 134k | $242k | 4% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 119k | $219k | 100% | Mar 2024 |
|
| First Hawaiian Bank | 47k | $85k | 0% | Mar 2024 |
|
| Us Bancorp | 31k | $56k | 0% | Mar 2024 |
|
| Virtus Investment Advisers | 26k | $47k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 10k | $18k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 4.0k | $7.0k | -96% | Mar 2024 |
|
| Bank Of Montreal | 3.0k | $5.4k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 3.0k | $5.4k | 0% | Mar 2024 |
|
| Capital Analysts | 2.0k | $4.0k | 0% | Mar 2024 |
|
| Bank of America Corporation | 2.0k | $3.6k | -50% | Mar 2024 |
|
| Morgan Stanley | 1.0k | $1.8k | 0% | Mar 2024 |
|
Who sold out of Neurocrine Biosciences Inc Note 2.250 5/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sona Asset Management | Sep 2023 | 18M | $26B |
| CSS | Dec 2023 | 8.9M | $15M |
| Two Sigma Investments | Dec 2023 | 1.5M | $2.6M |
| Sunrise Partners Limited Partnership | Dec 2023 | 847k | $1.5M |
| Leucadia National Corporation | Dec 2023 | 20k | $35k |
| Brian McDonald | Sep 2023 | 5.0k | $7.4k |
| Jpmorgan Chase & Co | Dec 2023 | 4.0k | $6.9k |
| Advisor Group Holdings | Dec 2023 | 1.0k | $1.7k |